Skip to main content
. 2013 May 2;28(5):769–774. doi: 10.3346/jkms.2013.28.5.769

Table 2.

Independent risk factors for poor visual acuity (VA) improvement after intravitreal ranibizumab treatment for exudative age-related macular degeneration

graphic file with name jkms-28-769-i002.jpg

*Odds ratios and confidence intervals adjusted for other variables in the respective models by logistic regression analysis. AMD, age-related macular degeneration; BMI, body mass index; CI, confidence interval; CMT, central macular thickness; OR, odds ratio; WC, waist circumference.